Breast Cancer Awareness Month is an international health campaign that’s held every October. The month aims to promote screening and reduce the risk of the disease, which affects 2.3 million women worldwide. Known best for its pink theme color, the […]
Read more »The Community Oncology Alliance (COA) is a non-profit dedicated solely to advocating for independent community oncology patients and practices. Their mission is to ensure that patients can receive the highest quality, most affordable, and accessible cancer care close to home. […]
Read more »Join us on October 4th where we are proud to be a sponsor of this wonderful free community event. There will be fun events for adults and kids through out the day, as well as free health screenings and education.
Read more »Research is a core focus at Eastern Connecticut Hematology & Oncology (ECHO). For over 35 years, we have excelled at bringing the latest advancements and treatments to patients across Eastern Connecticut. This includes offering our patients the possibility to participate in promising […]
Read more »The Beigene’s CELESTIAL clinical trial for chronic lymphocytic leukemia This clinical trial is for patients who have experienced progression of chronic lymphocytic leukemia. The usual first line treatment includes a BTK inhibitor (ibrutinib, acalabrutinib, zanubrutinib , pirtoburtinib) or the combination […]
Read more »Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow. It is the most common leukemia in adults. “CLL – the good cancer” – a message given by many doctors when they tell patients they […]
Read more »Make sure you have enrolled in our patient portal called Navigating Care. You can send messages to our care team, check labs and tests, and view appointments. It is the quickest way to get in touch with our care team […]
Read more »We continue to offer a cancer support group for women facing any form of cancer. Below are upcoming dates. Please note that in November and December, our meeting day and time will change.
Read more »Below is information on the INTerpath 009 study which is a clinical trial for early-stage non-small cell lung cancer (NSCLC). This clinical trial is trying to determine if an investigational study drug combination, when given after initial treatment and surgery, […]
Read more »A Phase 3 randomized double-blind study of adjuvant pembrolizumab with or without V940 in participants with resectable Stage II to IIIB (N 2) non-small cell lung cancer who are not achieving pCR after receiving neoadjuvant pembolizumab with platinum-based doublet chemotherapy […]
Read more »
